These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 757310)

  • 1. Properties of ribonucleotide reductase from Ehrlich tumor cells; multiple nucleoside diphosphate activities and reconstitution of activity from components.
    Cory JG
    Adv Enzyme Regul; 1978; 17():115-31. PubMed ID: 757310
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on mammalian ribonucleotide reductase inhibition by pyridoxal phosphate and the dialdehyde derivatives of adenosine, adenosine 5'-monophosphate, and adenosine 5'-triphosphate.
    Cory JG; Mansell MM
    Cancer Res; 1975 Feb; 35(2):390-6. PubMed ID: 1109803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of ribonucleotide reductase in mammalian cells.
    Cory JG; Mansell MM; Whitford TW
    Adv Enzyme Regul; 1976; 14():45-62. PubMed ID: 987694
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
    Cory JG; Mansell MM; Whitford TW
    Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of the ribonucleotide reductase enzyme from Ehrlich tumor cells.
    Cory JG; Fleischer AE; Munro JB
    J Biol Chem; 1978 May; 253(9):2898-901. PubMed ID: 565357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoordinate changes in the components of ribonucleotide reductase in mammalian cells.
    Cory JG; Fleischer AE
    J Biol Chem; 1982 Feb; 257(3):1263-6. PubMed ID: 7035447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of ribonucleotide reductase activity at low enzyme concentrations by polyethylene glycol.
    Kucera R; Paulus H
    Enzyme; 1988; 39(2):115-8. PubMed ID: 2456207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.
    Cory JG; Fleischer AE
    Cancer Res; 1979 Nov; 39(11):4600-4. PubMed ID: 498090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential substrate properties of mammalian ribonucleotide reductase.
    Cory JG; Cory AH; Downes DL
    Adv Exp Med Biol; 1994; 370():631-5. PubMed ID: 7660984
    [No Abstract]   [Full Text] [Related]  

  • 10. Uridine diphosphate reductase of Ehrlich ascites tumor is insensitive to hydroxyurea.
    Murayama J; Morita T; Fukui N; Moriyama Y; Fujimura S
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1104-8. PubMed ID: 3884001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside 5'-triphosphate analogs as positive and negative effectors of mammalian ribonucleotide reductase.
    Cory JG; Sato A; Bacon PE; Rey DA
    Cancer Biochem Biophys; 1985 Jun; 8(1):23-8. PubMed ID: 3896468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the properties of mammalian ribonucleotide reductase toward its substrates.
    Cory JG; Downes DL; Cory AH
    Adv Enzyme Regul; 1996; 36():3-15. PubMed ID: 8869737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular weight of Ehrlich tumor cell ribonucleotide reductase and its subunits: effector-induced changes.
    Cory JG; Fleischer AE
    Arch Biochem Biophys; 1982 Sep; 217(2):546-51. PubMed ID: 6753748
    [No Abstract]   [Full Text] [Related]  

  • 14. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
    Cory JG; Fleischer AE
    Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the cytidine 5'-diphosphate and adenosine 5'-diphosphate reductase activities of mammalian ribonucleotide reductase.
    Cory JG; Mansell MM
    Cancer Res; 1975 Sep; 35(9):2327-31. PubMed ID: 167952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ribonucleotide reductase activity in intact mammalian cells.
    Hards RG; Wright JA
    Arch Biochem Biophys; 1984 May; 231(1):17-28. PubMed ID: 6372693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
    Sato A; Cory JG
    Cancer Res; 1981 May; 41(5):1637-41. PubMed ID: 6783298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the allosteric properties of nuclear exoribonuclease from Ehrlich ascites tumor.
    Lazarus HM; Sporn MB
    Biochemistry; 1971 Feb; 10(3):505-10. PubMed ID: 5101340
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
    Cory JG; Sato A; Lasater L
    Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256
    [No Abstract]   [Full Text] [Related]  

  • 20. Aurintricarboxylic acid and polynucleotides as novel inhibitors of ribonucleotide reductases.
    Baumann H; Hofmann R; Lammers M; Schimpff-Weiland G; Follmann H
    Z Naturforsch C Biosci; 1984; 39(3-4):276-81. PubMed ID: 6375189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.